Research
Hormonal
Weight loss under Semaglutid therapy can be comparable to bariatric surgical intervention.
Semaglutid may be a viable alternative for patients who are not candidates for surgery.
StrongSupportsmedium confidence
Die Gewichtsreduktion unter dieser Therapie ist teils schon mit bariatrisch-chirurgischer Intervention vergleichbar.
Why this rating
The claim is based on comparative effectiveness stated in the abstract.
Source
Adipositas – eine behandlungsbedürftige chronische Erkrankung
Svenja Meyhöfer et al. · DMW - Deutsche Medizinische Wochenschrift · 2022
otherCited 7×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →